Cno Financial Group, Inc. CNO
We take great care to ensure that the data presented and summarized in this overview for CNO Financial Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CNO
View all-
Black Rock Inc. New York, NY14.7MShares$539 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$500 Million0.01% of portfolio
-
State Street Corp Boston, MA4.82MShares$177 Million0.01% of portfolio
-
Richard Pzena Pzena Investment Management LLC4.58MShares$168 Million0.53% of portfolio
-
Franklin Resources Inc San Mateo, CA4.27MShares$157 Million0.04% of portfolio
-
Lsv Asset Management Chicago, IL4.19MShares$154 Million0.32% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA4.16MShares$153 Million0.58% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.69MShares$136 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA2.54MShares$93.5 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C32.53MShares$92.9 Million0.1% of portfolio
Latest Institutional Activity in CNO
Top Purchases
Top Sells
About CNO
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on worksite and group sales for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed index annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. CNO Financial Group, Inc. markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company sells its products through agents, independent producers, and direct marketing. CNO Financial Group, Inc. was founded in 1979 and is headquartered in Carmel, Indiana.
Insider Transactions at CNO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 18
2024
|
Rocco F Tarasi Iii Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
4,500
-5.81%
|
$166,500
$37.51 P/Share
|
Dec 17
2024
|
Rocco F Tarasi Iii Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
2,500
-3.13%
|
$92,500
$37.73 P/Share
|
Dec 16
2024
|
Rocco F Tarasi Iii Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
1,484
-1.82%
|
$56,392
$38.02 P/Share
|
Nov 26
2024
|
Paul H. Mc Donough Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
1,540
-0.9%
|
-
|
Nov 18
2024
|
Eric R Johnson Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
3,978
-0.63%
|
$155,142
$39.09 P/Share
|
Nov 12
2024
|
Eric R Johnson Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
30,704
-4.61%
|
$1,197,456
$39.77 P/Share
|
Nov 12
2024
|
Eric R Johnson Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,290
+7.15%
|
$820,640
$16.42 P/Share
|
Nov 11
2024
|
Jeremy David Williams Chief Actuary |
SELL
Open market or private sale
|
Direct |
4,783
-7.15%
|
$191,320
$40.09 P/Share
|
Nov 11
2024
|
Jeremy David Williams Chief Actuary |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+10.32%
|
$123,200
$16.42 P/Share
|
Nov 08
2024
|
Matthew J. Zimpfer EVP and General Counsel |
SELL
Bona fide gift
|
Direct |
2,000
-0.76%
|
-
|
Oct 01
2024
|
Jessica A Turner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,632
+50.0%
|
$89,488
$34.36 P/Share
|
Sep 05
2024
|
Jeanne L. Linnenbringer Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
5,435
-12.61%
|
$184,790
$34.26 P/Share
|
Sep 05
2024
|
Karen De Toro President, Worksite Division |
SELL
Open market or private sale
|
Direct |
1,925
-3.09%
|
$65,450
$34.7 P/Share
|
Sep 04
2024
|
Jeanne L. Linnenbringer Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,786
-3.98%
|
$60,724
$34.61 P/Share
|
Sep 04
2024
|
Karen De Toro President, Worksite Division |
SELL
Open market or private sale
|
Direct |
3,740
-2.87%
|
$127,160
$34.62 P/Share
|
Sep 03
2024
|
Jeanne L. Linnenbringer Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
5,364
-5.41%
|
$182,376
$34.91 P/Share
|
Sep 03
2024
|
Jeanne L. Linnenbringer Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+8.39%
|
$78,200
$17.38 P/Share
|
Sep 03
2024
|
Karen De Toro President, Worksite Division |
SELL
Open market or private sale
|
Direct |
3,605
-2.62%
|
$122,570
$34.88 P/Share
|
Sep 03
2024
|
Mary R Henderson Director |
SELL
Bona fide gift
|
Direct |
2,310
-2.97%
|
-
|
Aug 09
2024
|
Jeanne L. Linnenbringer Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,940
-7.95%
|
$122,140
$31.67 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 673K shares |
---|---|
Bona fide gift | 1.91K shares |
Exercise of conversion of derivative security | 63.6K shares |
Payment of exercise price or tax liability | 6.55K shares |
Payment of exercise price or tax liability | 238K shares |
---|---|
Bona fide gift | 39.7K shares |
Open market or private sale | 290K shares |